Overactive bladder: onabotulinumtoxinA as treatment

Online course on effective management of pathophysiological conditions affecting the lower urinary tract (overactive bladder and neurogenic detrusor overactivity)

COURSE CONTENT:

Module 1. OnabotulinumtoxinA clinical data

Chapter 1: What is onabotulinumtoxinA?

Chapter 2: How does onabotulinumtoxinAwork in the bladder?

Chapter 3: Evidence for onabotulinumtoxinA in OAB

Chapter 4: Evidence for onabotulinumtoxinA in NDO

Module 2. OnabotulinumtoxinA in practice

Chapter 1: Practical considerations before treatment

Chapter 2: Administration in OAB

Chapter 3: Administration in NDT

Chapter 4: Aftercare and re-treatment

Chapter 5: A fully informed patient

Chapter 6: Setting up an onabotulinumtoxinA service

Learning Objectives

OnabotulinumtoxinA clinical data

Chapter 1: What is onabotulinumtoxinA?

• Gain a background on onabotulinumtoxinA: the molecule, and its applications in a variety of disease indications

Chapter 2: How does onabotulinumtoxinAwork in the bladder?

• Gain a detailed understanding of how onabotulinumtoxinA works in the bladder
• Understand the sensorimotor action of onabotulinumtoxinA in OAB and NDO

Chapter 3: Evidence for onabotulinumtoxinA in OAB

• Understand the efficacy and safety profile of onabotulinumtoxinA for OAB
• Understand the impact on QoL for patients with OAB who receive onabotulinumtoxinA injections

Chapter 4: Evidence for onabotulinumtoxinA in NDO

• Understand the efficacy and safety profile of onabotulinumtoxinA for NDO
• Understand the QoL impact of onabotulinumtoxinA for patients with NDO

OnabotulinumtoxinA in practice

Chapter 1: Practical considerations before treatment

• Explore who is eligible for onabotulinumtoxinA therapy
• Understand the equipment needed and preparations required before treating a patient with onabotulinumtoxinA
• Understand other practical considerations that you need to have addressed before administering onabotulinumtoxinA

Chapter 2: Administration in OAB

• Understand all procedural considerations for onabotulinumtoxinA administration in OAB, whether you are a first time or repeat injector conducting your work in an office or a theater

Chapter 3: Administration in NDT

• Understand how to prepare onabotulinumtoxinA using two 100 Unit vials for NDO
• Understand how to prepare onabotulinumtoxinA using one 200 Unit vial for NDO

Chapter 4: Aftercare and re-treatment

• Understand what is required post-treatment in order to ensure your patients receive the best possible care
• Review when re-treatment should be considered according to clinical trial data

Chapter 5: A fully informed patient

• Learn how to appropriately educate patients about onabotulinumtoxinA: the product and the procedure
• Learn ways of allaying patients' potential anxieties and misconceptions about onabotulinumtoxinA
• Understand how to guide patients' expectations in terms of efficacy and potential side effects

Chapter 6: Setting up an onabotulinumtoxinA service

• Understand the practical considerations for setting up an onabotulinumtoxinA service
• Understand the steps required to secure funding for your service
• Understand how to develop an implementation plan for your service

Learning Modules

Module 1: OnabotulinumtoxinA clinical data

• Chapter 1: What is onabotulinumtoxinA?
• Chapter 2: How does onabotulinumtoxinAwork in the bladder?
• Chapter 3: Evidence for onabotulinumtoxinA in OAB
• Chapter 4: Evidence for onabotulinumtoxinA in NDO

Module 2: OnabotulinumtoxinA in practice

• Chapter 1: Practical considerations before treatment
• Chapter 2: Administration in OAB
• Chapter 3: Administration in NDT
• Chapter 4: Aftercare and re-treatment
• Chapter 5: A fully informed patient
• Chapter 6: Setting up an onabotulinumtoxinA service

At a glance

• Last updated on: Jan 1, 2022
• Publication date: March 2015
• Available languages: English
• Duration: Approx. 120 minutes
• Target group: junior or senior urologists
• Topic: OAB and NDO
• CME: 2 European CME credits (ECMEC)